Solutions · Medical Societies & Patient Advocacy Groups

Define the episode of care for your field. Your members record it.

Specialty and patient registries depend on retrospective abstraction, so completeness decays and outcomes after the visit go unrecorded. A Circle runs on a protocol your experts write, captures each answer inside the visit and from patients at home, and returns comparative measures to members as data arrives, as MOTIV™ does with OREF.

5 solutions for societies and advocacy groups

Why medical societies and patient advocacy groups partner with RegenMed.

Each runs on the same four pillars: the Observational Protocol, the Circle, the closed system and the technical stack. The methodological detail sits in the linked white papers.

1

Your organization defines the episode

Set the protocol for your specialty or condition, from first symptom to long-term outcome, including care no billing code captures.

A Circle opens with one testable statement, and the society is the right body to write it. Authorizing the Observational Protocol makes the society the methodological authority for the specialty's evidence rather than a customer of a registry vendor. MOTIV™ is the working example: a national TKA Circle, authorized by OREF and open to participating sites.

2

Capture inside the visit, and after it

Members answer through inCytes™ while the patient is in front of them, and patients report through Benchmarc™ whether or not they return.

Registry participation usually means re-entering data after clinic, which is why completeness falls away in later follow-up years. With capture in the encounter and at home, follow-up continues for the whole episode, and there is no abstraction workforce to fund.

3

A funding source for the organization

When a Circles Dataset is licensed, most of the value is allocated under the Ownership Agreement, which can include a share for the convening society and the protocol’s authors.

For societies, that means the clinicians who captured and attested the data. For patient advocacy groups, it also means your members directly: every Circles Dataset traces back to patients who consented to its use, and Circle Health Coin lets each patient earn the value their own data creates, under terms a smart contract enforces automatically. The mechanics are detailed in the relevant white papers.

4

Evidence for guidelines, coverage and rare disease

Guideline and policy questions answered on records traceable to their source; Medicare coverage registries; natural history that FDA now accepts as rare disease confirmatory evidence.

Guideline committees currently weigh trial data against registry data of uncertain provenance. Because each value carries its attesting clinician, credential and timestamp, and verification uses zero-knowledge proofs computed at the data source, a committee can test individual records instead of accepting an aggregate — the conditions the FDA's December 2025 guidance describes.

5

A member benefit with a return

Comparative outcome reports, Circle Hours, co-authored publications and a share of license value, in place of an unpaid reporting duty.

Recruitment into registries stalls because the work sits with the clinician and the value sits with the vendor. On the Circles Platform participating members are Circle Members: they hold compilation ownership, their consented patients hold their own rights on Circle Health Coin, and licensing happens on the Circles Datasets Exchange with the proceeds flowing back to the Circle.

By the numbers
87% / 93%
MOTIV™ physician and patient survey completion
National total knee replacement Circle designed with OREF
$15.4B
Spent each year by U.S. physician practices reporting quality measures
785 hours per physician
27
Medicare coverage determinations requiring evidence development
Including transcatheter valves and leadless pacemakers
95%
Of about 10,000 rare diseases without an FDA-approved treatment
Affecting about 30 million Americans

Sources: Mercuri and Wickline, JOEI (2026); Casalino et al., Health Affairs (2016); CMS Coverage with Evidence Development; NCATS Rare Diseases Fact Sheet.

Frequently asked questions
Does this replace our existing registry?

It can, or it can run alongside it. A Circle does not import registry data; it records new episodes to your protocol, and each answer can carry your registry’s codes so results are comparable.

Who controls the protocol and the attribute set?

The convening organization and its clinical leads, with patients where the group chooses. The protocol names the questions and Attributes, and its version history travels with the dataset, so a later committee can see what was asked when each Case was enrolled.

What does participation ask of your organization?

Clinical leads to set the protocol, which RegenMed drafts with AI-assisted research for them to finalize, and support in recruiting members. No IT infrastructure is required.

How is member and patient data protected if a dataset is licensed?

Licensed datasets are de-identified under HIPAA, and each patient’s consent terms stay attached to the data. Members are paid only by the volume and completeness of their data, never by product or referral.

Convene one Circle in your community and see what your members already know.

Talk to our team